Table 2.
Top 5 causative drug categories responsible for acute and chronic SOCs in SJS/TEN patients.
Name of causative drugs | No. of patients (%) |
---|---|
Acute SOCs | N = 67 |
Antiepileptics | 15 (22.4) |
Phenytoin | 2 (3.0) |
Carbamazepine | 4 (6.0) |
Oxcarbazepine | 5 (7.5) |
Lamotrigine | 2 (3.0) |
Zonisamide | 2 (3.0) |
Antibiotics | 12 (17.9) |
Cephalexin | 1 (1.5) |
Cefuroxime | 1 (1.5) |
Ceftazidime | 1 (1.5) |
Ceftriaxone | 1 (1.5) |
Norfloxacin | 1 (1.5) |
Levofloxacin | 1 (1.5) |
Moxifloxacin | 1 (1.5) |
Amoxicillin | 3 (4.5) |
Vancomycin | 2 (3.0) |
Allopurinol | 8 (11.9) |
NSAIDs | 7 (10.4) |
Diclofenac | 3 (4.5) |
Ibuprofen | 1 (1.5) |
Mefenamic acid | 3 (4.5) |
Sulfa drugs | 6 (9.0) |
Sulfasalazine | 3 (4.5) |
Sulfonamide | 3 (4.5) |
Miscellaneous | 19 (28.4) |
Chronic SOCs | N = 9 |
NSAIDs | 4 (44.4) |
Diclofenac | 2 (22.2) |
Mefenamic acid | 1 (11.1) |
Cold medicine | 19 (11.1) |
Anti-epileptics | 2 (22.2) |
Carbamazepine | 1 (11.1) |
Lamotrigine | 1 (11.1) |
Antibiotics | |
Cefuroxime | 1 (11.1) |
Sulfa drugs | |
Sulfasalazine | 1 (11.1) |
Tenofovir | 1 (11.1) |
SOCs, Severe ocular complications.
NSAIDs, Non-steroidal anti-inflammatory drugs.